JNJ-61186372, an Fc enhanced EGFR/cMet bispecific antibody, mediates EGFR and cMet downmodulation and therapeutic efficacy preclinically through monocyte / macrophage mediated trogocytosis

Vijayaraghavan, S; Lipfert, L; Bushey, B; Chevalier, K; Henley, B; Lenhart, R; Beqiri, M; Millar, HJ; Packman, K; Lorenzi, MV; Laquerre, S; Moores, S

CANCER RESEARCH, 2020; 80 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索